Claude H. Nash, PhD
Chief Executive Officer and Chairman

Paul J. Leibowitz, PhD
Chief Technology Officer and Director

Julian M.E. Lee, MA (Cantab), ACA
Chief Financial Officer and Director

Sandra Panem, PhD
Director

Robert J. Powell, Ph.D., MBA
Vice President, University Liaison

Eric R. Leibowitz, Esq.
In-House Counsel



Francis J. Bullock, PhD

Gerald Malone, MA, LLB

Seth A. Rudnick, MD

Natalie S. Rudolph, PhD



Bingham McCutchen LLP
US corporate counsel

Fasken Martineau LLP
UK corporate counsel

Claude Nash, Ph.D. brings a wealth of experience to the company from his work in academia and the pharmaceutical industry and as founder of a biotechnology company. Most recently, Dr. Nash served as Vice President for Research and Development at University of Maryland Biotechnology Institute (UMBI), responsible for sponsored programs and technology portfolio management. UMBI is focused on creating programs of excellence, providing advanced training and stimulating economic development in the field of biotechnology.

Dr. Nash has more than 30 years of pharmaceutical industry experience, which includes advancing more than 20 compounds into clinical trials, five of which are currently approved products. Dr. Nash founded ViroPharma Incorporated in December 1994 and served as the President, CEO and/or Chairman of the board until 2002. He led the company through its initial public offering and raised more than $450 million through several additional secondary offerings.

Prior to founding ViroPharma, Dr. Nash served as Vice President for Infectious Disease and Oncology at Schering Plough Research Institute. Previously, he held various positions with Sterling Drugs, SmithKine Beecham, and Eli Lilly. Dr. Nash currently serves on the board of directors of Adolor Incorporated and is the Chairman of Accera Incorporated.

He received the Charles Porter Award from the Society for Industrial Microbiology and is a member of The American Academy of Microbiology, Phi Kappa Phi, Sigma Xi and Beta, Beta, Beta, Biological honor societies. He holds a Ph.D. degree in microbiology.